Watchlist Price Alert

Clarus Therapeutics Inc. (CRXT)

NASDAQ: CRXT · Real-Time Price · USD

0.05

-0.02 (-27.54%)

At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q2 2020
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Jun 30, 2020
Net Income	-10.69M	-14.87M	-19.73M	-2.77M	-18.11M	10.55M
Depreciation & Amortization	7K	7K	7K	18K	n/a	n/a
Stock-Based Compensation	451K	432K	108K	560K	n/a	n/a
Other Working Capital	878K	-568K	865K	34.88M	676.16K	n/a
Other Non-Cash Items	n/a	n/a	12.46M	-61.51M	17.22M	-10.55M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-7.26M	-2.84M	-2.18M	29.43M	710.98K	n/a
Operating Cash Flow	-17.5M	-17.27M	-9.33M	-34.27M	-183.66K	10.55M
Capital Expenditures	n/a	-10K	-5K	-20K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-10K	-5K	-20K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	-7.74M	n/a	n/a	n/a
Other Financial Acitivies	2.02M	-3.79M	21.54M	49.19M	n/a	n/a
Financial Cash Flow	2.02M	-3.79M	13.8M	49.19M	n/a	n/a
Net Cash Flow	10.04M	-17.28M	4.46M	-633.42M	-183.66K	10.55M
Free Cash Flow	-17.5M	-17.28M	-9.34M	-34.29M	-183.66K	10.55M